Management of bacterial infections in children with asthma

Matti Korppi1

  • 1Paediatric Research Centre, Tampere University and University Hospital, Tampere, Finland. matti.korppi@uta.fi

Insights

Respiratory infections are common triggers for childhood asthma exacerbations. This review explores the role of various pathogens and antibiotics in pediatric asthma development and management.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Asthma Research

Background:

  • Respiratory infections are primary triggers for childhood asthma exacerbations.
  • The mechanisms linking viral infections like rhinovirus to chronic asthma remain unclear.
  • The pathogenic roles of human bocavirus, Mycoplasma pneumoniae, and Chlamydia species in pediatric asthma are under investigation.

Purpose of the Study:

  • To review current knowledge on the association between respiratory infections and childhood asthma.
  • To focus on the role of specific pathogens (viruses, bacteria) in asthma pathogenesis and exacerbations.
  • To examine the impact of antibiotic use in incipient, exacerbated, and chronic stable pediatric asthma.

Main Methods:

  • Literature review of studies on respiratory infections and pediatric asthma.
  • Analysis of evidence linking specific pathogens to asthma exacerbations and chronic disease.
  • Evaluation of the role of antibiotics in different asthma stages.

Main Results:

  • Rhinovirus is a known risk factor for chronic asthma, though mechanisms are elusive.
  • Human bocavirus, Mycoplasma pneumoniae, and Chlamydia species are implicated in pediatric wheezing and asthma.
  • While common in infections, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis lack evidence for direct asthma pathogenesis.

Conclusions:

  • Respiratory infections significantly impact childhood asthma, necessitating further research into pathogen-specific roles.
  • Understanding these associations is crucial for developing targeted therapeutic strategies, including judicious antibiotic use.
  • Further investigation is needed to elucidate pathogen-specific mechanisms and optimize antibiotic stewardship in pediatric asthma management.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.